Patents by Inventor John W. Benbow

John W. Benbow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110130365
    Abstract: The present invention provides Formula (1A) XN O R 3 HN R 5 O R 4 R 2 R 1 (1A) 5 compounds that act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by the glucokinase enzyme, where X, R 1, R 2, R 3, R 4, and R 5 are as described herein.
    Type: Application
    Filed: July 15, 2009
    Publication date: June 2, 2011
    Inventors: John W. Benbow, Jihong Lou, Jeffrey A. Pferfferkorn, Meihua M. Tu
  • Patent number: 7671072
    Abstract: The present invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof in the treatment of, inter alia, conditions, diseases, and symptoms including, inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: March 2, 2010
    Assignee: Pfizer Inc.
    Inventors: John W. Benbow, Daniel W. Kung
  • Patent number: 7485641
    Abstract: The invention provides compounds of formula (1), and the pharmaceutically acceptable salt thereof, wherein R1, n and R2 are as described herein; compositions thereof; and uses thereof.
    Type: Grant
    Filed: June 18, 2007
    Date of Patent: February 3, 2009
    Assignee: Pfizer, Inc.
    Inventors: David W. Piotrowski, Yu Hui, John W. Benbow
  • Publication number: 20070299076
    Abstract: The invention provides compounds of formula (1), and the pharmaceutically acceptable salt thereof, wherein R1, n and R2 are as described herein; compositions thereof; and uses thereof.
    Type: Application
    Filed: June 18, 2007
    Publication date: December 27, 2007
    Inventors: David W. Piotrowski, Yu Hui, John W. Benbow
  • Patent number: 7202245
    Abstract: The present invention provides compounds of formula (I) the prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein Ra, Rb, R1, and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: April 10, 2007
    Assignee: Pfizer Inc.
    Inventors: John W. Benbow, Margaret Y. Chu-Moyer, Daniel W. Kung
  • Publication number: 20040192698
    Abstract: The present invention provides compounds of formula (I) 1
    Type: Application
    Filed: March 22, 2004
    Publication date: September 30, 2004
    Applicant: Pfizer Inc.
    Inventors: John W. Benbow, Margaret Y. Chu-Moyer, Daniel W. Kung